Comparison of msc-evs manufatured in 2D versus scalable 3D bioreactor systems
Sign Up to like & getrecommendations! Published in 2019 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2019.03.434
Abstract: Background & Aim There have been over 800 registered clinical trials using mesenchymal stem/stromal cells (MSCs) for therapeutic applications. Due to their potential as a key bioactive agent in regenerative medicine applications, MSC-derived extracellular vesicles… read more here.
Keywords: bioreactor; bioreactor systems; msc evs; cell ... See more keywords